Weidong Tong
Army Medical Center (Daping Hospital) · Army Medical University, China · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Weidong Tong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:42 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07683390 · Puborectalis Syndrome as a Phenotype of Dyssynergic Defecation in Chronic Constipation: a Comparative Study of Defecography,High-resolution Anorectal Manometry, and Pelvic Floor UltrasoundThird Military Medical University · completed · Dyssynergic Defecation, Puborectalis Syndrome, Impaired Rectal Evacuation · study director
- Ph3NCT07277907 · Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit ConstipationThird Military Medical University · recruiting · Slow Transit Constipation, Pharmacotherapy · study director
- N/ANCT07036588 · PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic LeakageThird Military Medical University · recruiting · Anastomotic Leak · principal investigator
- N/ANCT06675227 · Comparison of Electrolyte Beverages and Water as Solvents for Bowel PreparationThird Military Medical University · recruiting · Bowel Preparation Before Colonoscopy · principal investigator
- N/ANCT06155175 · Risk of NSAIDs on Anastomotic Leak for Rectal SurgeryThird Military Medical University · completed · Anastomotic Leak, Anti-Inflammatory Agents, Non-Steroidal · study director
- N/ANCT05352074 · STOPS Trial: Total vs Subtotal Colectomy for Slow Transit ConstipationThird Military Medical University · active not recruiting · Slow Transit Constipation, Surgery · study director
- N/ANCT04573738 · Safety and Feasibility Study of Robotic Assisted Transanal Total Mesorectal Excision for Rectal CancerThird Military Medical University · completed · Rectal Cancer, Perioperative Complication · study chair
- N/ANCT04304183 · Defecation Function and Quality of Life in the Patients Treated With Surgery for Slow Transit ConstipationThird Military Medical University · unknown · Defecation Function, Quality of Life · study chair
- N/ANCT02252250 · Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal CancerThird Military Medical University · completed · Rectal Neoplasms · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:42 UTC. The ranking covers the 200 most relevant of 117 PubMed records, and a shared surname and initials can bring in a namesake. All 117 on PubMed
- Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.J Clin Oncol · 2005770 citationsRCR 15.8
- Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.Clin Cancer Res · 2003557 citationsRCR 10.8
- Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.J Clin Oncol · 2002509 citationsRCR 11.9
- 364 citationsRCR 12.5
- Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.J Clin Oncol · 1998357 citationsRCR 8.9
- 306 citationsRCR 18.8
- Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.J Clin Oncol · 1997244 citationsRCR 6.4
- 225 citationsRCR 8.3
- Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.J Clin Oncol · 2010188 citationsRCR 4.0
- 181 citationsRCR 5.8